SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001628280-24-001154
Filing Date
2024-01-11
Accepted
2024-01-11 16:03:33
Documents
12

Document Format Files

Seq Description Document Type Size
1 SC TO-C arcutis-toxc.htm SC TO-C 39612
2 EX-99.1 exhibit991-toxc.htm EX-99.1 11519
3 exhibit991-toxc001.jpg GRAPHIC 81037
4 exhibit991-toxc002.jpg GRAPHIC 79048
5 exhibit991-toxc003.jpg GRAPHIC 120211
6 exhibit991-toxc004.jpg GRAPHIC 136947
7 exhibit991-toxc005.jpg GRAPHIC 127028
8 exhibit991-toxc006.jpg GRAPHIC 76067
9 exhibit991-toxc007.jpg GRAPHIC 120068
10 exhibit991-toxc008.jpg GRAPHIC 176820
11 exhibit991-toxc009.jpg GRAPHIC 109651
12 exhibit991-toxc010.jpg GRAPHIC 136488
  Complete submission text file 0001628280-24-001154.txt   1655970
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filed by) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91349 | Film No.: 24529272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)